Recs
November 06, 2009 – Comments (1) | RELATED TICKERS: GSI , PRX
that were expecting even bigger EPS , GSI posts .22 eps being pummeled from opening gap down to $4.27 after earlier hitting $4.59
Another is PRX which posted .76 eps and also is being pummeled from opening gap of $23.67 to current $22.62
PRX looking to get approvals on an additional $6.5B worth of drugs.
PRX Total revenue nearly doubled to $294.8 million
Analysts on average expected earnings of 49 cents a share on revenue of $290.4 million, according to Thomson Reuters I/B/E/S.
PRX said it currently has about 27 abbreviated new drug applications pending with the U.S. health regulators, 13 of which the company believes have first-to-file or first-to-market opportunities with a brand value of about $6.5 billion.
View More
Terms & Conditions
RSS Headlines
Fool UK